Russell Kevin Klass

Russell Kevin Klass discloses dealings in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) to SEDI. In total, 16 filings cover trades dated from 10 June 2024 to 5 August 2026.

On the market, this insider has only ever bought: 15 purchases, €242k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise.

A typical purchase (the median) is worth €12k. Across 13 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 7 August 2026, reports an option exercise of €14k in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). The last insider purchase was made public on 14 November 2025, 344 days ago. Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.